Moderator | 19th Annual SOCS Scientific Symposium
Dr. King is professor of dermatology at Yale School of Medicine, specializing in inflammatory skin diseases. He has pioneered the use of Janus kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, atopic dermatitis, granulomatous disorders, and other conditions.
Click here for more information on the Valeant Research Award.
Read published peer-reviewed articles written your by Skin of Color Society members
Did You Know
Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.
By 2042, more than 50% of the US population will have skin of color.